Israel reports first cases of combined Omicron subvariants BA.1 and BA.2

Israel's Health Ministry announced on Wednesday that the country had identified something the world had not yet seen: two cases of a coronavirus strain that merged two different omicron subvariants into a single hybrid. The discovery happened at Ben Gurion Airport, where routine PCR testing caught what officials described as a previously unknown combination of BA.1 and BA.2—two branches of the omicron family that had, until this moment, circulated as separate threats.

Both patients carried only mild illness. They reported fever, headaches, and muscle aches, the kind of symptoms that resolve on their own. Neither required hospitalization or specialized medical intervention. The Health Ministry said it would continue monitoring the situation and provide updates if circumstances changed, but the initial picture suggested this hybrid strain, at least in these two cases, was not producing severe disease.

The discovery raised immediate questions about what this combination might mean. BA.2, one of the two subvariants in the hybrid, had already earned a reputation as unusually transmissible. Research from Denmark's Statens Serum Institute, which tracks infectious disease patterns, showed BA.2 spreading roughly 1.5 times faster than BA.1. More striking was the genetic distance between them. The mutations that separated BA.1 from BA.2 were more numerous and more significant than the differences that had once separated the original omicron variant from alpha—a shift that had reshaped the pandemic landscape worldwide.

Some scientists had taken to calling BA.2 the "silent omicron" because its genetic signature made it harder to identify through standard PCR tests, though the World Health Organization had not yet classified it as a variant of concern. The WHO did, however, sound a warning about the pace at which omicron was spreading globally and the risk that new variants would continue to emerge from that circulation.

The timing of this discovery placed it within a broader moment of viral evolution. Just months earlier, in December, Israel had reported the first case of "flurona"—a simultaneous infection with both influenza and coronavirus—in a thirty-year-old unvaccinated woman who had recently given birth in Petah Tikva. That case had illustrated how the pandemic landscape was shifting as multiple respiratory viruses competed for hosts. Now, with this hybrid omicron strain, the question was whether recombination between subvariants represented a new phase of that evolution.

In the twenty-four hours before the announcement, Israel had recorded 6,310 new COVID cases. Since the pandemic began, the country had lost 10,401 people to the disease. Against that backdrop, two cases of a hybrid strain—mild ones at that—might have seemed like a small footnote. But in virology, the first detection of a new combination is always worth watching. It signals that the virus is not simply spreading; it is reshaping itself in real time.